[Form 4] Eastman Chemical Company Insider Trading Activity

Rhea-AI Filing Summary

Julie A. McAlindon, SVP, Regions & Chief Supply Chain Officer and director of Eastman Chemical Co. (EMN), purchased 2,000 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.4294 per share. After the transaction she beneficially owned 12,731 shares directly and had indirect ownership of 867 shares through an ESOP. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.

Positive

• Insider purchase reported: Executive and director acquired 2,000 shares, showing direct insider buying activity.
• Complete transaction details provided: Transaction date, price ($68.4294), and post-transaction holdings (12,731 direct, 867 indirect via ESOP) are disclosed.
• Form properly executed: Signature filed by power of attorney (Mark D. Austin) with a date of 08/28/2025.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchase of 2,000 EMN shares reported; increases direct holdings to 12,731 shares.

The filing documents a straightforward open-market purchase by an executive officer and director. The transaction date, price per share, and resulting share counts are explicitly disclosed. This type of disclosure provides transparency about insider activity but does not include information about size relative to outstanding shares or any planned trading program.

Corporate Governance Expert

TL;DR: Officer and director reported a personal stock purchase; Form 4 properly executed by POA.

The report identifies the reporting persons roles, the relationship to the issuer, and records the acquisition with signature executed under power of attorney. The filing meets disclosure expectations for Section 16 reporting by stating transaction code, price, and post-transaction holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAlindon Julie A.

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Regions & Chf SupChn Ofcr

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		2,000	A	$68.4294	12,731	D
Common Stock								867	I	By ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Julie A. McAlindon	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Julie A. McAlindon report on Form 4 for EMN?

She reported purchasing 2,000 shares of Eastman Chemical Co. common stock on 08/27/2025 at $68.4294 per share.

How many EMN shares does Julie A. McAlindon beneficially own after the reported transaction?

She beneficially owns 12,731 shares directly and 867 shares indirectly through an ESOP after the purchase.

What is Julie A. McAlindons role at Eastman Chemical Co. as stated in the filing?

The filing lists her as SVP, Regions & Chief Supply Chain Officer and as a director.

When was the Form 4 signed and by whom?

The form is signed by Mark D. Austin by power of attorney for Julie A. McAlindon on 08/28/2025.

Does the Form 4 disclose any derivative transactions for Julie A. McAlindon?

No; Table II for derivative securities contains no entries in this filing.